Skip to Content

Press Releases

The information and content in this site has been released in the past by Express Scripts Holding Company or its predecessor and wholly-owned subsidiary, Express Scripts, Inc. (together, Express Scripts). These contents may no longer be current. The passage of time can render information stale, and you should not rely on the continued accuracy of any such material beyond the date of issuance. On the date released, some of the contents in this site may have contained statements that were then "forward-looking statements," based upon then current expectations, forecasts and assumptions that involved risks and uncertainties, then enumerated by Express Scripts that could cause actual outcomes and results to differ materially. To the extent any information is forward-looking, it is intended to comply with the safe harbor for forward-looking information as of the date of issuance (for more information, view our forward-looking statement). Express Scripts disclaims any intention or obligation to update or revise the contents of this site, including but not limited to any forward-looking statements made at the time the information was first released, whether as a result of new information, future events or otherwise.

Archived Press Releases

Date Title and Summary
Toggle Summary Express Scripts Names Novak as Vice President, Healthcare Services Sales and Palmer as Vice President, Commercial Sales
ST. LOUIS (February 10, 1998) --- Express Scripts, Inc. (NASDAQ: ESRX) announced today the appointment of two senior sales executives. Tim Novak has been named to the position of Vice President, healthcare services sales, and Marc Palmer has been named Vice President, commercial sales.
Toggle Summary Express Scripts Reports Record Revenues and Income for Fourth Quarter and Full Year in 1997
Annual Revenues Grow 59.1 Percent to $1.2 Billion; Net Income Rises 27.9 Percent ST. LOUIS, Feb. 10, 1998—Express Scripts, Inc. (NASDAQ:ESRX) today reported that revenues for 1997 reached a record $1.2 billion, up 59.1 percent from $773.6 million in 1996.
Toggle Summary Express Scripts Announces Agreement to Purchase ValueRx from Columbia/HCA
$445 Million Transaction Will Create Largest Independent PBM Managing More Than $4.0 Billion in Drug Claims ST. LOUIS, February 20, 1998 – Express Scripts, Inc. (NASDAQ:ESRX) today announced that it has executed a definitive agreement to purchase ValueRx, the pharmacy benefit management (PBM)
Toggle Summary Express Scripts Announces Long-Term Agreement with NYLCare Health Plans
ST. LOUIS, March 16, 1998—Express Scripts, Inc. (NASDAQ:ESRX) today announced that it has reached agreement with NYLCare Health Plans, Inc., a subsidiary of New York Life Insurance Company, for an extension of its agreements to provide members of NYLCare’s HMO with pharmacy benefit management and
Toggle Summary Express Scripts Completes Acquisition of ValueRx from Columbia/HCA
ST. LOUIS, April 1, 1998—Express Scripts, Inc. (NASDAQ:ESRX) today announced that it has completed the acquisition of ValueRx from Columbia/HCA Healthcare Corporation approximately six weeks after signing the definitive acquisition agreement. The purchase makes Express Scripts the nation’s largest
Toggle Summary Express Scripts Reports Strong Gains in Revenue and Income for First Quarter
Net Income Up 29.3 Percent on Revenue Growth of 41.8 Percent ST. LOUIS, April 23, 1998—Express Scripts, Inc. (NASDAQ:ESRX) today announced that revenues for first quarter 1998 increased 41.8 percent to a record $371.4 million from $262.0 million for the period in 1997.
Toggle Summary Express Scripts Announces Alliance with Cole Managed Vision
ST. LOUIS, June 17, 1998—Express Scripts, Inc. (NASDAQ:ESRX) announced today that it will close its PhyNet vision care subsidiary and transfer certain functions of its Express Scripts Vision Corporation unit to Cole Managed Vision, a subsidiary of Cole National Corporation (NYSE:CNJ).
Toggle Summary Express Scripts/ValueRx Report Identifies Reasons for the Rapid Increase in Pharmacy Expenses
1997 Drug Trend Report Analyzes Prescription Drug Costs and Trends St. Louis (July 1, 1998) – America’s increasing consumption of prescription drugs and its fondness for new drugs are among the trends that drove prescription drug costs to a record 16.1 percent increase in 1997, according to a new
Toggle Summary Express Scripts Reports Strong Revenue and Income Growth
168.7 Percent Revenue Gain and Operating Profit Growth Reflect Success with Integration of ValueRx ST. LOUIS, July 28, 1998—Express Scripts, Inc. (NASDAQ:ESRX) today reported second quarter 1998 revenues increased 168.7 percent to $807.4 million compared with $300.5 million for the period one
Toggle Summary Express Scripts, Inc. Announces Expansion of Riverport Facility
New Building to House Company’s Corporate Headquarters St. Louis (August 20, 1998) – Express Scripts, Inc. has announced it is breaking ground on a new building adjacent to its existing facility located in Maryland Heights, Mo. The future three-story building will sit on 11.4 acres in the Riverport
Toggle Summary Express Scripts, Inc. Declares 2-For-1 Stock Split
ST. LOUIS, October 12, 1998—Express Scripts, Inc. (NASD: ESRX) today announced that its board of directors has approved a two-for-one stock split of its Class A and Class B common stock to be effected in the form of a stock dividend. The stock split is for shareholders of record as of Oct.
Toggle Summary Express Scripts Reports Continued Strong Revenue and Income Growth
Net Income Increased 31 Percent In Third Quarter; ValueRx Integration Continues On Track ST. LOUIS, October 21, 1998—Express Scripts, Inc. (NASD: ESRX) today reported net income grew by 31.2 percent to $11.3 million from $8.6 million in the prior year, and rose 28.9 percent on a diluted per share
Toggle Summary Express Scripts, Inc. Completes 2-For-1 Stock Split
ST. LOUIS, November 1, 1998— Express Scripts, Inc. (NASD: ESRX) announced today that the previously disclosed two-for-one stock split of its Class A and Class B common stock was effective at the close of trading Oct. 30. The stock closed at a pre-split price of 97.69.
Toggle Summary Blue Cross and Blue Shield of Massachusetts Selects Express Scripts/ValueRX to Manage Pharmacy Benefits
BOSTON and ST. LOUIS, February 1, 1999 -- Blue Cross and Blue Shield of Massachusetts (BCBSMA) members will soon have their pharmacy benefits managed through Express Scripts, one of the nation’s largest pharmacy benefit management firms, the two firms announced today.
Toggle Summary Express Scripts To Acquire Diversified Pharmaceutical Services
ST. LOUIS, February 9, 1999 -- Express Scripts, Inc. (NASDAQ: ESRX), one of the nation’s largest pharmacy benefit management (PBM) firms, announced today that it has signed a definitive agreement to acquire Diversified Pharmaceutical Services (DPS), a subsidiary of SmithKline Beecham (NYSE: SBH).
Toggle Summary Express Scripts Fourth Quarter EPS Rises 30 Percent
  ValueRx Integration Goals Achieved as Company Prepares to Add DPS ST. LOUIS, FEBRUARY 16, 1999—Express Scripts, Inc. (NASD: ESRX) today reported that fourth quarter 1998 net income grew by 31.8 percent to $11.9 million from $9.0 million in the fourth quarter of 1997, and earnings per
Toggle Summary Express Scripts Files $350 Million Primary Common Stock Offering
ST. LOUIS, MARCH 18, 1999 - Express Scripts, Inc. (NASD: ESRX) today announced an offering for approximately 4,500,000 primary shares, or approximately $350 million, of its Class A Common Stock. The offering is being managed by Credit Suisse First Boston, BT Alex.
Toggle Summary Express Scripts, Inc. Unveils Plans For Online Pharmacy and Drug Information Site
St. Louis, Mo., March 29, 1999 - Express Scripts, Inc. (NASDAQ: ESRX), the nation’s leading independent full-service pharmacy benefit manager (PBM), announced today plans for a dual online effort targeted to an initial customer base of more than 36.5 million people.
Toggle Summary Express Scripts Completes Acquisition of Diversified Pharmaceutical Services
ST. LOUIS, APRIL 1, 1999 -- Express Scripts, Inc. (NASDAQ: ESRX) announced today that it has completed the acquisition of Diversified Pharmaceutical Services (DPS) from SmithKline Beecham Corporation (NYSE: SBH). "We’re pleased to announce the completion of the DPS acquisition just seven
Toggle Summary Express Scripts First Quarter EPS Increases 38 Percent
ST. LOUIS, April 21 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) today reported net income of $13.5 million for the three months ended March 31, 1999, a 37 percent increase over $9.9 million in the same period of 1998. The company earned 40 cents per share on a diluted basis, a 38 percent
Toggle Summary Express Scripts Plans $200 Million Senior Note Offering
ST. LOUIS, May 24 /PRNewswire/-- Express Scripts, Inc. (Nasdaq: ESRX) today announced that it plans to offer $200 million in unsecured senior notes due in 2009, through a private placement to qualified institutional buyers. The notes will not be registered under the Securities Act and may not be
Toggle Summary Express Scripts Completes Stock Offering
ST. LOUIS, June 10 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) today announced that it has completed its offering of 4,500,000 shares of its Class A Common Stock at $61.00 per share. The company has granted the underwriters a maximum of 675,000 shares to cover over-allotments of shares.
Toggle Summary Express Scripts Completes Debt Offering
ST. LOUIS, June 11 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) today announced that it has completed the sale of $250 million of 9-5/8% Senior Notes Due 2009 through a private placement to qualified institutional buyers. The notes are not registered under the Securities Act and may not be
Toggle Summary Express Scripts Underwriters Exercise Common Stock Overallotment
ST. LOUIS, June 24 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) today announced that underwriters of its recent 4,500,000 share Class A Common Stock offering exercised their overallotment option and purchased 675,000 shares of Class A Common Stock from the company at $61.00 per share.
Toggle Summary Express Scripts, Inc. Invites You to Join Its Outcomes Conference Call On The Web
ST. LOUIS, June 28 /PRNewswire/ -- Barrett Toan, president and chief executive officer of Express Scripts, hosts a media teleconference to discuss the company's 1998 Drug Trend Report. Also participating will be Fred Teitelbaum, Ph.D., principal author of the report; conference keynoter Arthur
Toggle Summary Depression-Treating Drugs Lead Record-Setting Pharmacy Benefit Cost Rise
ST. LOUIS, June 29 /PRNewswire/ -- America's growing use of depression- treating drugs like Prozac, Zoloft and Paxil made antidepressants the biggest contributors to a record-setting pharmacy benefit cost increase of 16.8 percent last year, according to a study by the country's largest independent
Toggle Summary Medication Prescribing Patterns Vary Widely Between, Within States and Therapy Classes
ST. LOUIS, June 29 /PRNewswire/ -- Where you live plays a big role in how many and which medicines you take according to a study of regional prescription use presented here today by University of Arizona researcher Brenda Motheral, Ph.D., at a national conference of health plans and benefits
Toggle Summary Express Scripts Announces Second Quarter Results
ST. LOUIS, July 21 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced second quarter 1999 pro forma net income of $16.6 million, or 42 cents per diluted share. The pro forma calculation is before one-time charges and assumes that the company's equity and debt offering took place on
Toggle Summary Express Scripts and PlanetRx.com Announce Internet Pharmacy Agreement
Express Scripts and PlanetRx.com Announce Internet Pharmacy Agreement Combined Strengths Significantly Accelerate Express Scripts' Online Capabilities ST. LOUIS, Aug. 31 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX), the nation's largest independent pharmacy benefit management firm, today
Toggle Summary Express Scripts, Inc. Announces Extension of Exchange Offer
ST. LOUIS, Sept. 9 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced today that it has elected to extend its offer to exchange $250,000,000 of its outstanding 9 5/8% Senior Notes due 2009 for an equal amount of notes which have been registered with the Securities and Exchange
Toggle Summary Express Scripts Commences Consent Solicitation
Express Scripts Commences Consent Solicitation ST. LOUIS, Sept. 17 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX), the nation's largest independent pharmacy benefit management firm, today announced that it has commenced a consent solicitation with respect to proposed amendments to the
Toggle Summary Express Scripts, Inc. Completes Exchange Offer; Company will Exchange Notes Today
ST. LOUIS, Sept. 21 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced that, as of 5 p.m. on Sept. 14, 1999, the expiration date of its exchange offer, $250 million, or 100 percent, of its outstanding 9-5/8% Senior Notes due 2009 had been tendered in its offer to exchange $250 million
Toggle Summary Express Scripts, Inc. Announces Completion of its Consent Solicitation
ST. LOUIS, Oct. 5 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX - news ) announced that it successfully completed its previously announced consent solicitation with respect to its 9 5/8% Senior Notes due 2009 (the ``Securities''). As set forth in the Consent Solicitation, amendments to the
Toggle Summary Express Scripts, Inc. Announces Amendments to the Indenture Governing its 9 5/8% Senior Notes due 2009
Express Scripts, Inc. Announces Amendments to the Indenture Governing its 9 5/8% Senior Notes due 2009 ST. LOUIS, Oct. 8 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced that it has entered into amendments to the Indenture under which its 9 5/8% Senior Notes due 2009 were issued.
Toggle Summary PlanetRx.com and Express Scripts Today Complete Acquisition Transaction
PlanetRx.com Becomes Exclusive Online Pharmacy for Express Scripts' 36 Million Members SOUTH SAN FRANCISCO, Calif. and ST. LOUIS, Oct. 14 /PRNewswire/ -- PlanetRx.com, Inc. (Nasdaq: PLRX) and Express Scripts, Inc. (Nasdaq: ESRX) today announced that PlanetRx.com has completed the acquisition of
Toggle Summary Express Scripts, Inc. Announces Amendments to the Indenture Governing its 9 5/8% Senior Notes Due 2009 Have Become Effective
ST. LOUIS, Oct. 18 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced that amendments to the Indenture, under which its 9-5/8% Senior Notes due 2009 (the "Notes") were issued, became effective on October 13, 1999. The amendments to the Indenture allowed the Company to sell assets of
Toggle Summary Express Scripts Announces Third Quarter Results
Achieves Record Net Income ST. LOUIS, Oct. 20 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX - news ) announced third quarter 1999 net income of $17.5 million, or 45 cents per diluted share, excluding an after-tax extraordinary charge associated with the payoff of the company's Term B debt of
Toggle Summary Blue Shield of California Selects Express Scripts to Provide Mail Pharmacy Services for Its 1.6 Million Members
ST. LOUIS, Oct. 29 /PRNewswire/ -- Express Scripts, Inc. announced today that it has signed a contract with Blue Shield of California to provide mail pharmacy services and Internet refill services to the plan's 1.6 million members. "We're excited to have the opportunity to partner with one of
Toggle Summary Express Scripts Reaffirms Strong Results and Positive Outlook
ST. LOUIS, Nov. 1 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) today reaffirmed its positive business outlook, based on strong operating results and proven business strategy. Barrett Toan, Express Scripts president and chief executive officer, stated, "We have recently announced record net
Toggle Summary Express Scripts Names Five Members to Board of Directors Appointees Combine Extensive Industry and Corporate Finance Experience
ST. LOUIS, Jan. 26 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) today announced the election of five members to its board of directors. Frank J. Borelli, Barbara B. Hill, Stuart L. Bascomb, Gary G. Benanav and Gary E. Wendlandt will assume their directorships effective Jan.
Toggle Summary Express Scripts Announces 65% Increase in Fourth Quarter Pro Forma Net Income
ST. LOUIS, Feb. 9 /PRNewswire/ -- 2000-Express Scripts, Inc. (Nasdaq: ESRX) announced pro forma fourth quarter 1999 net income of $19.6 million, or 50 cents per diluted share, and year-to-date 1999 pro forma net income of $67.3 million, or $1.77 per diluted share.
Toggle Summary Pharmacy Market Heading for Major Reorganization
New Drugs, Empowered Consumers, Aging Baby Boomers Set the Stage ST. LOUIS, Feb. 16 /PRNewswire/ -- New prescription drugs, empowered consumers and aging baby boomers led the top ten developments on the pharmaceutical landscape in 1999, according to a report issued by Express Scripts (Nasdaq: ESRX
Toggle Summary Express Scripts Calls 1st Quarter Outlook 'Achievable'
(Copyright (c) 2000, Dow Jones & Company, Inc.) By Desiree J. Hanford (This repeats an article originally published late Thursday.) ST. LOUIS (Dow Jones)--Based on the company's performance so far this quarter, Express Scripts Inc. (ESRX) thinks Wall Street's outlook for the first quarter is
Toggle Summary Express Scripts Online Forum on Drug Formulary Development and Manufacturer Discounts
ST. LOUIS, March 8 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) has scheduled an informational forum for investors. CEO Barrett Toan and CFO George Paz will host the forum, which will be broadcast live via the Internet: Wednesday, March 8, 2000 4 p.m. Central (5 p.m.
Toggle Summary Express Scripts Corrects Dow Jones Report
ST. LOUIS, April 12 /PRNewswire/ -- Express Scripts, Inc., (Nasdaq: ESRX) will announce its first quarter financial results at the close of market on Wednesday, April 19, 2000. The management conference call for investors will be held on Thursday, April 20, 2000 at 10:00 a.m. central.
Toggle Summary Express Scripts Ranked by Fortune and Forbes
ST. LOUIS, April 12 /PRNewswire/ -- Express Scripts, Inc., (Nasdaq: ESRX) has been ranked for the first time among the top 500 companies in the United States by both Fortune and Forbes magazines, published this month. Express Scripts was also included earlier this year in the Forbes Platinum List,
Toggle Summary Humana Selects Practice Patterns Science to Develop Integrated Clinical Database
ST. LOUIS and LOUISVILLE, Ky., April 17 /PRNewswire/ -- Practice Patterns Science, Inc. (PPS) a subsidiary of Express Scripts, Inc. (NASD: ESRX), the nation's largest independent pharmacy benefit management firm, announced today that it has signed a contract with Humana Inc.
Toggle Summary Express Scripts First Quarter Net Income Up 58 Percent; Diluted EPS Rises 38 Percent Cash Flow from Operations Grows to $61 Million
ST. LOUIS, April 19 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) announced first quarter 2000 net income of $21.4 million, or 55 cents per diluted share. This is a 58 percent increase in net income and a 38 percent increase in diluted earnings per share compared with $13.5 million, or 40
Toggle Summary Express Scripts Selects Allscripts to Expand Electronic Prescribing Nationwide
Prescription Drug Ordering and Processing Made Easier for Physicians, Patients, Health Plans ST. LOUIS and CHICAGO, April 26, 2000 -- Express Scripts, Inc. (Nasdaq: ESRX), and Allscripts, Inc. (Nasdaq: MDRX) today announced an agreement intended to accelerate physician adoption of the
Toggle Summary Express Scripts Authorizes Repurchase of Up to 2.5 Million Shares
ST. LOUIS, May 9 /PRNewswire/ -- Express Scripts, Inc. (Nasdaq: ESRX) today announced that the Executive Committee of its Board of Directors authorized a modification to the terms of the Company's previously-announced stock repurchase program to permit the Company to repurchase up to 2.5 million